WO2001029558A1 - Dispositif a bande d'essai dote d'une partie de pretraitement a couvercle - Google Patents

Dispositif a bande d'essai dote d'une partie de pretraitement a couvercle Download PDF

Info

Publication number
WO2001029558A1
WO2001029558A1 PCT/FI2000/000914 FI0000914W WO0129558A1 WO 2001029558 A1 WO2001029558 A1 WO 2001029558A1 FI 0000914 W FI0000914 W FI 0000914W WO 0129558 A1 WO0129558 A1 WO 0129558A1
Authority
WO
WIPO (PCT)
Prior art keywords
layers
pretreatment
lid
test device
sample
Prior art date
Application number
PCT/FI2000/000914
Other languages
English (en)
Inventor
Eivor Helena Svens
Original Assignee
Oy Medix Biochemica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oy Medix Biochemica Ab filed Critical Oy Medix Biochemica Ab
Priority to JP2001532099A priority Critical patent/JP2003512624A/ja
Priority to AU79286/00A priority patent/AU7928600A/en
Priority to EP00969615A priority patent/EP1222458A1/fr
Publication of WO2001029558A1 publication Critical patent/WO2001029558A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow

Definitions

  • the present invention is related to a test device with a lid- provided pretreatment portion mounted on the same backing support as a test strip and having means for controlled regulation of sample and diluent flow.
  • a method for directly carrying out assays from samples generally requiring more or less time consuming pretreatment procedures with said device is also disclosed.
  • Some biological samples especially such samples which are taken for making diagnoses from whole blood, serum, urine, feces, saliva, sputum, synovial fluid, etc. require pretreatment procedures including removal of particles, agglutination, chemical treatments, release of specific components, immuno- capture, etc.
  • Some problems are related to said known systems . Said problems are for example backflow of diluting buffers and overflow, i.e. redundant fluid may pass the edges of the filtering means, leaving the reagents in the reagent layer and causing disturbances in the detection zone.
  • Another problem connected with said known methods and devices is that only one filtering pad or layer is often not sufficient to retain all blood cells and all interfering factors are not retained either.
  • the objective of the present invention is to provide a test device with a test-strip and improved lid-provided pretreatment portion having means for regulating the sample and diluent flow.
  • Said device is useful in emergency situations, especially for use in ambulances wherein coagulation and centrifugation is not possible to carry out or in which said steps are too time consuming.
  • On the test device of the present invention even complicated immunological analysis can be performed rapidly with great accuracy without pretreatment of the sample.
  • the test device can be modified to meet the requirements in a multitude of different test methods .
  • the invention relates to a test device for obtaining a controlled regulation of sample and diluent flow.
  • Said test device has a pretrea- ting portion for treating the sample and removing interfering substances and particles before performing the assays on a test-strip placed on the backing support (1) .
  • the pretreatment portion is provided with a lid (2) having an aperture (3) .
  • Said lid covers and protects the pretreatment system having one or more pretreatment layers (4) horizontally stapled upon each other and assembled in capillary flow contact with the test strip (5) , which is placed on the lid-provided backing support (1) .
  • the backing support (1) and the lid (2) are provided with means for keeping the layers (4) in the pretreatment system in their correct positions and to connect them with the test strip (5) .
  • Said means for securing and fixing the position of the layers are responsible for a controlled regulation of the flow of the sample solution.
  • Said means also form an excess liquid collecting compartment (6) , which enables rapid addition of buffer or other liquids in order to allow more efficient dilution of sample and reagents impregnated into the layers.
  • the compartment (6) minimizes the negative effects of overflow and backflow and enables an even and controlled passage through each layer in a predetermined order and subsequently into the test strip (5) where the result is recordable as one or more visable or readable zones.
  • the invention relates to a method for carrying out a rapid bed-side or field test without pretreating the sample.
  • the sample is added into the aperture (3) in the lid (2) on the backing support (1) of the test device and a diluent or aqueous driving solution is added.
  • the diluent may contain agents, which are essential for properly carrying out the test .
  • the diluent which may be a buffer or pure water is capable of driving the sample solution and diluents through the layers in the pretreatment system in a controlled manner. Particles are captured and interfering substances are removed or allowed to react by using physical and/or chemical means in the layers of the pretreatment system. Superfluous or excess fluid is collected in the compartment formed by the bar (9.1) in the lid and the flanking support (8.1) and the bar (9.4) in the lid-portion of the backing support.
  • Fig. 1 is a side view of a lid-provided backing support (1) and the lid (2) with a hinge (A) .
  • the lid is snapped in place with the means for attaching the lid (C) to protect the layers in the pretreatment system.
  • Fig. 2 is a schematic view from above of the test device with a closed lid (2) snapped on the backing support (1) and the test strip (5) fixed in its correct position.
  • the lid (2) is provided with a shaped or non-shaped aperture (3) into which the sample solution and possible diluents or driving solutions can be added.
  • Fig. 3 is a sectional side-view of the lid-provided backing support (1) with the lid (2) open.
  • the aperture (3) for adding sample solution is seen as an intersection.
  • Two pretreatment layers (4.1) and (4.2) as well as the test strip (5) are schematically shown.
  • Fig. 4 shows a view from above of the lid-provided backing support (1) with the lid (2) open and the aperture (3) shown as a round dot or spheric area and with the pretreatment layers (4.1) and (4.2) as well as the test strip (5) placed in their correct positions.
  • Fig. 5 is a sectional side view of the lid-provided backing support (1) with the lid (2) snapped on the backing support (1) and covering and protecting the pretreatment layers (4.1) and (4.2) .
  • the pretreatment layers are in capillary flow contact with the test strip through the conjugate pad (B) . All layers are placed in their correct positions.
  • Fig. 6 is a sectional view seen from above with a transparent closed lid (2) and the aperture (3) snapped on the backing support (1) . Due to the transparency the lid-covered pretreatment layers (4) , which normally are not seen, can be seen in their correct positions and in capillary flow contact with the test strip (5) . The transparency is not a prerequisite in the present invention. Transparency was used during developmental work for experimental purpose to enable studies of what is going on in the different layers.
  • Fig. 7 is a sectional side view of the lid-provided backing support (1) with the lid (2) open and without pretreatment layers and without the test strip.
  • the means for securing and fixing the layers in their correct positions are shown. These means include taps (7) , flanking supports (8) and bars (9) .
  • Fig. 8 is a schematic picture viewed from above of the lid- provided backing support (1) with the lid (2) open without pretreatment layers and without the test strip.
  • Fig. 9 is a sectional side view of the lid-provided backing support (1) with the lid (2) snapped in place without pretreatment layers and test strip. In this Figure the space provided for the layers is clearly indicated.
  • Fig. 10 is a sectional view seen from above with a transparent closed lid (2) snapped on the backing support (1) and without the pretreatment layers and without the test strip.
  • the aperture (3) is shown in this Figure as well as the taps (7) and the side wall protrusions forming the flanking supports (8) .
  • the bar (9.4) which forms the reservoir of the compartment is clearly indicated.
  • the term "means for securing and fixing the position of the layers” are responsible for a controlled regulation of the flow of the sample solution and appropriate diluents. They also form a compartment for collecting excess fluid or liquid. This compartment allows efficient dilution of reagents. It minimizes the effects of overflow. Simultaneously, negative backwash effects are avoided. The compartment enables an even and controlled passage through each layer in a predetermined order and subsequently into the test strip.
  • the "means for securing and fixing the position of the layers” are provided by taps, flanking supports and bars, which are longer or shorter protrusions present in the plastic lid and the lid-portion of the backing support of the device . The means have somewhat different functions.
  • backwash effect and/or “backflow effect” means the phenomenon when the sample solution and the liquid, acting as a diluent, drives the sample solution in the wrong direction, i.e. in a direction opposite to the intended one. In the worst case, the sample flows over the reaction area and the reagents are washed back. In the present invention, uncontrolled backwash is not possible.
  • the negative backwash effect is abolished, because the excess fluid is collected behind the pretreatment layers in a compartment, which is later emptied, when the excess fluid from the compartment migrates through the filter layers into the conjugate pad and the reagent area of the test strip by capillary forces of the absorbing pad in the opposite end of the test strip.
  • tap means smaller protrusions, such as pegs or tags on the bottom of the plastic backing of the device . Said taps support the filtering means and prevent them from lying directly on the backing support. Alternatively, a grid can be used. Thus, the sample solution and the diluent cannot flow along the backing support. In other words, the sample solution is prevented from passing into the test strip without first passing the filters.
  • flanking support means protrusion in the backing support which keep the pretreatment layers in fixed positions.
  • One flanking support in the rear of lid-portion of the backing support assists in forming the excess fluid compartment.
  • the flanking supports in the side walls also prevent excess fluid from migrating into the test strip without first passing the pretreatment layers .
  • bars mean ridges and ribs which can be “toothed” in order to provide a better grip. Such a “toothed bar” is present in the lid and keeps the test strip in a firm grip.
  • the bars may also form the wall of the compartment for excess fluid and prevents the excess fluid from flowing under the filter layers.
  • the bars together with the flanking supports also fix the pretreatment layers in their correct positions.
  • test strip and/or "test stick” means a laminated strip or stick comprising for example a nitrocellulose or nylon membrane mounted on a backing.
  • the test strips or sticks are provided with reagents preferably immunoreagents such as mono- or polyclonal antibodies and further provided with recordable or visible markers or labels.
  • the test sticks can alternative be enzymatic, chemical or biochemical.
  • aperture means a shaped or non- shaped hole for adding the sample and/or diluent.
  • test strip is an immunochromatographic test producible as follows:
  • a nitrocellulose or nylon membrane is mounted on a plastic backing or between plastic strips and is provided with a conjugate pad in close contact with one end of a nitrocellulose or nylon membrane and with an absorbent pad attached to the other end of the membrane.
  • a narrow zone on the nitrocellulose or nylon membrane is coated with a monoclonal antibody against a specific component. Coloured or fluorescent latex particles, as well as colloidal particles, gold sols, magnetic particles, etc. may be coated with another antibody preferably a monoclonal antibody against the same component .
  • the coated particles are dried on a zone preferably close to the pretreatment portion of the strip or in a layer placed in the pretreatment portion. The diameter of the particles is so small that they can flow freely through the pores and strip materials.
  • the layers and the test strips are placed on a plastic backing so that they are in a capillary flow contact of the sample liquid to test strip through the appropriate filter layers .
  • test strip is, however, not restricted to the test strip embodiment described above.
  • test devices and determinations which require pretreatment of the sample can be used in the present test device including immuno- assays as well as enzymatic, chemical or biochemical test strips .
  • the test device of the present invention is provided with a lid-provided pretreatment area, comprising one or more layers, preferably of a hydrophilic, bibulous material, stapled upon each other. They provide means for physical or chemical treatment of the sample.
  • Said pretreatment area is provided with a lid or cover of plastic material with good wetting properties and means for keeping the layers fixed in a predetermined position with each others and with the test strip.
  • the cover or lid is optionally loose or attached to the backing support by fastening means such as hinges or pivots.
  • the fastening means can be placed on any side of the backing support, but the most preferable place is in the near, i.e. at the outer or upper end of the backing support. If the hinges are placed on either side, the flow of the sample solution may not be even, i.e. it can be different on different sides of the layers. When the pretreatment layers and the test strip are assembled the lid is snapped over the pretreatment portion.
  • the layers in the pretreatment system comprise one or more different layers, which allow physical as well as chemical pretreatment of the sample.
  • Said physical treatment includes separation or removal of certain components or particles or means for regulating the mobility of the components in the sample solution.
  • filters or membranes with different pore sizes or with shaped pores are used.
  • filters having different so called V-pores i.e. having pores with different diameters on each side of the filter or filters having different pore sizes on each side are used for separating particles of different sizes in the sample solution.
  • the layers in the pretreatment portion can in addition to providing physical treatment comprise means for chemical treatment of the sample .
  • Said means for chemical treatment are filters or membranes containing certain compounds or compositions acting as agglutinating, coagulating, lytic, buffering and ionic strength regulating agents as well as immunocap- turing agents .
  • the layers can also be used as carriers for so called labels or markers, including coloured, phosphorescent or fluorescent latex particles, colloids, gold sols, lipo- somes, etc. It is also possible to add chemical substance, which are capable of releasing specific components from the substances which are to be determined.
  • the test device comprises a supporting back preferably prepared by good quality, wettable, plastic material, such as polypropens . Because of the hinges or pivots, it is essential that the material is substantially non-brittle. Furthermore, the material should not contain any disturbing chemicals. It is for example not recommendable to use mold releasing agents or plasticizers for the preparation of the lid and backing support. Surface treatments are not recommendable.
  • the backing support is provided with a lid preferably made of the same material as the backing support.
  • the lid covers the pretreatment portion and simultaneously fixes the test strip in capillary flow contact with the pretreatment layers.
  • the sample solution has to pass all the required layers before entering the test strip by capillary flow.
  • the backing support and the lid of the test device act as a protector for the test strip during storage and transport. Otherwise the test strip itself is not covered.
  • the inside of the lid, as well as the pretreatment portion of the test device, is provided with means, including taps (7) , flanking supports (8) and bars (9), which fix the layers of the pretreatment portion firmly with each others and the test strip.
  • the contact between the test strip and the pretreated sample solution is made feasible only through the aperture in the lid.
  • the sample solution flows by capillary forces through the pretreatment layers into the test strip.
  • the lid is constructed to enable a firm capillary flow contact between the sample solution and the test strip through the pretreatment layers, e.g. the filters in the desired and predetermined order.
  • the pretreated sample solution migrates only through the pretreatment layers into the test strip. Redundant or excess fluid is temporally collected in a compartment (6) formed by the bar (9.4) in the lid portion of the backing support .
  • test strip can be placed into the test device during the manufacture and sold as a ready to use disposable kit.
  • test strip, test device and layers for the pretreatment portion can be sold separately and assembled in desired manner before use.
  • the sample can be whole blood, serum, urine, feces, saliva, sputum, synovial fluid, amniotic fluid, but also environmental samples of different forms. Generally, it is essential that particular and/or solid material can be removed from the sample. This can be achieved with filtering means such as a pad with suitable pore sizes. Sometimes, the sample has to be chemically treated in order to separate interfering or disturbing components. Sometimes, some specific or active components in the substances to be determined from the sample have to be released before they can be determined. Such components are for example epitopes or active sites in certain proteins or haptens . The release can be carried out e.g. by extraction using different reagents, such as detergents, reducing agents, acids, etc. The agents remove for example sulphur- bridges, lipid, etc.
  • the test device is preferably used with samples requiring different kinds of pretreatments .
  • the lid-provided portion of the test device may contain one layer of material, or several layers of the same material or of different types of materials . These materials can e.g. have different pore sizes, and may be used as pre- filters . They can be impregnated with different kinds of reagents and they may act as reagent layers or as immunocap- ture layers . These layers may be used separately or in any combination with each other.
  • sample specimen When the sample specimen is whole blood, separation of blood cells is usually required. This can be achieved by preferable using two layers of material in close contact with the lateral flow test strip.
  • the upper layer is preferably acting as a sample pad.
  • the sample pad together with the underlaying filter separates blood cells from whole blood allowing plasma or sera to migrate forward to the test strip.
  • the lid-provided portion may contain layers impregnated with reagents for eliminating these interfering substances .
  • the serum specimen can be applied to a layer acting as a sample pad and eluted with a buffer containing such reagents.
  • a driving solution either water or preferably a buffer is added.
  • the driving solution dissolves and mixes the sample and reagents and drives them through the pretreatment layer (s) into the test strip and the zone where the result can be read.
  • the buffer is known to cause problems such as backflow.
  • the present invention solves said backflow problem by collecting any liquid flowing backwards into the compartment behind the filter (s), but thereafter the compartment is efficiently emptied by capillary forces and all sample and reagents are transferred to the test strip.
  • the lid-provided portion may contain one or more layers of filters with the same or with different pore sizes.
  • a prefilter with a coarse pore structure may lay on the top of one pretreatment layer with a fine pore structure. Large and small particles can subsequently be filtered away before the sample liquid reaches the test strip.
  • the sample specimen is a urine sample, having for example a very low pH value, caused e.g. by a preservative, or a very low ionic strength, it may preferably be pretreated in one or several buffered layers before the sample liquid reaches the test strip.
  • sample specimen is saliva, sputum, synovial fluid or amniotic fluid it may be preferable to use mucous dissolving agents impregnated into the layers of the pretreatment portion.
  • the sample is added to the test device through the aperture in the lid of the pretreatment portion.
  • the volume of the sample can be such, that no additional reagent solution is needed.
  • a diluent solution preferably an aqueous buffer is necessary in order to get a flow of liquid from the pretreatment portion to the end of the test strip in the device.
  • sample liquid to the opening in the lid is preferable added drop-wise.
  • the first drop of liquid spreads through the top layer of the filters, i.e. the hydrophilic, bibulous sample pad.
  • the further drops flow through the sample pad into the underlaying filter layer and spread horizontally into the back compartment (6) in the lid-portion of the backing support.
  • the filter materials are all in close contact with each other, and with the bibulous filter part or conjugate pad (B) of the test strip (5) .
  • the pretreatment layers or filters are laying on taps (7) in the plastic device, and they are in turn held in place by flanking supports (8) in such a way, that the liquid is forced to flow through the filter and/or reagent layers in a predetermined order and not along the inner surface of the plastic device.
  • the sample liquid with or without the diluent or driving solution is spread along the underlaying filter(s) (4), and wets the end of the test strip (5), i.e. the conjugate pad (B) .
  • the excess fluid collecting compartment (6) of the lid- portion in the rear end of the backing support is emptied as the liquid flows forward along the conjugate pad (B) and further into the membrane part of the test strip driven by capillary forces which are provided by the absorbant pad in the opposite end of the test strip (5) .
  • Microspheres e.g. latex particles covered with an antibody, dried upon the conjugate pad redissolve, and migrate forward with the liquid front into the reaction area on the membrane of the test strip.
  • the absorbent pad in contact with the membrane of the test strip absorbs excess liquid and ensures that the compartment (6) will be emptied.
  • the sample is preferably pipetted into the hole or aperture on the cover or lid of the test device and optionally a suitable buffer solution is added for driving the sample through the layers .
  • the solution is forced through a first filter layer which removes greater components or particles into the following layer. Behind the layers is a compartment (6) into which excess liquid can be collected so that it is not forced beside and over the pretreatment layers (4) into contact with the nitrocellulose or nylon membrane of the test strip (5) . Furthermore, the sides of the backing support (1) and the lid (2) is provided means (7, 8 and 9) for attaching the different layers in fixed positions.
  • the means provided are for example in form of a grid lattice or more preferably in the form of taps (7) .
  • the grid or taps (7) are supporting the pretreatment layers so that they do not touch the backing support (1) .
  • the flanking supports (8) prevent the sample solution from passing along the sides of the filters.
  • the lid (2) and support (1) is provided with bars (9) .
  • the lid (2) is provided with a toothed bar (9.3) which keeps the test strip in place.
  • the lid-portion of the backing support is also provided with a bar (9.4), which assisted with the flanking support (8.1) forms the compartment (6) for redundant or excess fluid.
  • the test is allowed to develop without any pos- sibly disturbing movements until the result is visible or readable.
  • the result is recorded directly. It is preferable that the amount of sample and diluent is such that solution is absorbed and not left in the excess liquid collecting compartment ( 6 ) .
  • test device of the present invention and the use thereof for performing analyses with a test strip or test stick is described in more detail by referring to the attached Figures 1-10, wherein the reference numbers and/or letters used refer to the corresponding features independent of the design of the test device .
  • Fig. 1 is a side view of a lid-provided backing support (1) with an edge and the lid (2) snapped in place with the means for closing (C) the lid by snapping to protect the layers in the pretreatment system.
  • the backing support and the lid portion are connected with suitable fastening means, such as hinges (A) or pivots placed in the rear of the test device in the most preferred embodiment of the present invention.
  • Fig. 2 is a schematic picture of the closed lid (2) snapped on the backing support (1) and with the pretreatment layers (not shown) hidden under the lid and the test strip (5) fixed in their correct position.
  • the lid (2) is provided with a preferably shaped aperture (3) into which the sample solution and a possible diluent or driving solution can be added and also with means for closing (C) the lid.
  • Fig. 3 is a sectional side-view of the lid-provided backing support (1) with the lid (2) open.
  • the aperture (3) for adding the sample solution is shown as an intersection and two pretreatment layers (4.1) and (4.2), which include for example a first filter pad (4.1) and a second filter pad (4.2) and the bibulous area of the test strip (5) are schematically shown as well as the fastening means or hinge (A) in the rear of the test device.
  • the conjugated area in which the filter (4.2) is in capillary flow contact with test strip (5) is indicated with the letter (B) and the means for closing (C) the lid by snapping over the pretreatment portion is indicated with (C) .
  • taps (7) and bars (9.1), (9.2) and (9.3) which support the layers in the pretreatment portion and a flanking support (8.1) and a bar (9.4) which form a compartment (6) or reservoir basin for excess or redundant fluid.
  • Fig. 4 shows a view from above of the lid-provided backing support (1) with the lid (2) open, the aperture (3) for adding sample and with the pretreatment layers (4.1) and (4.2) and the test strip (5) placed in the correct positions.
  • the flanking support (8.1) and bar (9.1) forming the reservoir compartment (6) as well as the side wall protrusions or flanking supports (8.2) preventing excess fluid from passing around the filters and the bars (9.1), (9.2) and (9.3) which fix the layers are also indicated.
  • the fastening means or hinge (A) and filter layer-test strip-connecting area, the conjugate pad (B) as well as the snapping or closing means (C) are schematically shown.
  • An enlarged view of one preferred embodiment of the toothed bar (9.3), which prevents the test strip from moving, is shown in detail seen from the rear end of the lid and the backing support .
  • Fig. 5 is a sectional side view of the lid-provided backing support (1) with the lid (2) with the aperture (3) snapped on the backing support and covering and protecting the pretreatment layers (4.1) and (4.2) and connected with the test strip (5), all placed in their correct positions.
  • the fastening means or hinge (A) and the connection area, conjugate pad (B) between the filter (4.2) and test strip (5) as well as the snapping region (C) are also schematically shown.
  • the taps (7) which support the layers as well as the flanking support (8.1) and the bar (9.4) which form the compartment (6) .
  • the compartment area collect excess fluid and prevents it from passing around the filters.
  • Fig. 6 depicts a view seen from above with a closed transparent lid (2) and the aperture (3) on the backing support (1) . Also seen are the layers of which (4.1) is a prefilte- ring pad and the filter (4.2) is connected with the test strip (5) . Side wall protrusions and/or flanking supports (8.2) are also shown on each side of the filter layers as well as a flanking support in the rear end (8.1) .
  • the area marked (B) indicates the filter-test strip connecting area, the conjugate pad and (C) the snapping area.
  • Fig. 7 is a cross-sectional side view seen from one side in longitudinal direction of the lid-provided backing support with the lid portion (2) open and without pretreatment layers and test strip.
  • the lid portion (2) is attached to the backing support (1) with hinges (A) , which preferably are placed in the rear of the lid portion of the backing support (1) and not on either side of the lid portion in order to avoid uneven mobility or flow of the sample fluid.
  • the backing support comprises two portions.
  • the lid portion being the sample pretreatment portion is covered by the lid (2) and the assay portion carries the test strip (not shown) .
  • the lid (2) is provided with a shaped aperture (3) and the backing support with a side wall in the backing support (1.1) the inside of which is shown in this Figure.
  • the lid (2) is snapped to the backing support (1) and the bars (9.1), (9.2) and (9.3) which can be of different heights and breadths can be used to fix the filtering layers. They act as fastening and supporting means for the layers and the test strip (not shown) . They can also be placed so that they form a separate compartment (6) for collecting excess or redundant sample fluid and enable an even flow into the test strip or test membrane.
  • the backing support (1) of the lid portion is also provided with flanking supports (8.2) and/or taps (7) of different heights which are adjusted so that they support differently shaped and sized filter layers.
  • the filter layers are of different thickness and different sizes (dimensions) .
  • the flanking support (8.1) and the bar (9.4) forms the compartment (6) which acts as a reservoir basin for redundant or excess sample fluid.
  • Fig. 8 is a schematic picture viewed from above of the lid- provided backing support (1) with the lid (2) open without pretreatment layers and test strip.
  • the lid (2) and the supporting back (1) are connected by the fastening means or hinge (A) .
  • the aperture (3) is a shaped hole into which the sample is added or pipetted.
  • the lid (2) is further provided with bars (9.1), (9.2) and (9.3) of different height which keep the different filter layers in desired places.
  • the bar (9.1) in the lid and the bar (9.4) and the flanking support (8.1) in the lid portion of the backing support forms a compartment (6) acting as a reservoir for redundant or excess sample solution.
  • the flanking supports (8.1) and (8.2) and the taps (7) are separating the reservoir of sample solution from the test strip and forces the fluid to pass the appropriate filter layers (not shown) .
  • Fig. 9 is a sectional side view of the lid-provided backing support (1) with the lid (2) closed without pretreatment layers and test strip.
  • the aperture (3) in the lid (2) is shaped to divert the sample and eluting buffer into the filter layers (not shown) .
  • Bars (9.1), (9.2), (9.3) and (9.4), flanking supports (8.1) and (8.2) and taps (7) which fix the position of the filters are shown.
  • the side wall (1.1) of the backing support (1) is shown from its inside.
  • the lid (2) and the supporting back (1) are connected by the fastening means or hinge (A) .
  • Fig. 10 depicts the test device seen from above and with a transparent closed lid (2) snapped by means for closing the lid and keeping it in place i.e. snapping means (C) on the backing support (1) and without the pretreatment layers and the test strip.
  • the hinges (A) are placed in the rear of the test device in the preferred embodiment of the present invention.
  • the aperture (3) as well as the flanking supports (8.2) and the taps (7) can be placed for example as indicated.
  • the flanking support (8.1) and the bar (9.4) forms a compartment (6) for excess or redundant sample solution.
  • Serum ferritin concentration indicates the level of iron stores of the body.
  • Ferritin is an early marker of iron deficiency anemia (IDA) because its concentration decreases before anemia has developed. Prelatent and latent anemia is detectable before a decrease in hemoglobin concentration can be observed.
  • IDA iron deficiency anemia
  • the rapid test described below for determining ferritin can be used to estimate the need for iron therapy during the pregnancy.
  • the test was performed on whole blood.
  • the cut-off value was about 40 ⁇ g/1 (calibrated against WHO 3rd International Standard, code 94/572) .
  • the positive test result indicated, that the risk of developing IDA later in pregnancy was small, and no iron therapy should be needed.
  • the negative test result indicated, that the risk of developing IDA was big, and therefore iron therapy should be recommended.
  • the test was based on lateral flow immunochromatography using monoclonal antibodies against human ferritin. One antibody was bound to colored microspheres , and another antibody was dispensed onto a membrane solid phase.
  • the test device was composed of a lateral flow test strip and filters for separation of red blood cells from whole blood mounted in the lid-provided pretreatment portion.
  • test device was assembled so that at first the test strip was placed into the plastic device, then the filter layers were mounted into their places, and finally the lid was closed.
  • the test device was packed into aluminium foil pouches together with silica gel bags.
  • test result was read visually or by a reader 5 minutes after addition of elution buffer.
  • One line (control line) in the test window indicated a negative test result.
  • Two lines (test line and control line) in the test window indicated a positive result.
  • Samples for environmental fungal analysis e.g. analysis for Sta.ch.ybo try s chartarum, were collected from suitable sites identified by the investigator as representing the contaminated area sufficiently.
  • the sample was taken from a site including building material, other substrate, accumulated dust etc.
  • the sample was transferred into a test tube containing buffer solution and shaken carefully.
  • the sample suspension was then transferred into a test device.
  • the test device consisted of an immunochromatographic test stick for recognizing Stachy- botrys chartarum and a pretreatment device.
  • the lid-provided pretreatment device was assembled by placing two pads of porous material in the plastic compartment. The first pad was impregnated with reagents that were capable of releasing anti- genic cell components present in the fungal cell wall.
  • the second pad was made of filtering material capable of removing large particles of fungal structure. If necessary, one more pad can be added, containing immobilized antibodies that capture components that might cause nonspecific reactions with the antibodies used in the immunochromatographic test stick. Sample suspension in buffer was pipetted into the aperture in the lid. Within 5 minutes, the sample liquid migrated through the pads for pretreatment and along the test strip. When fungal antigen were present a visible line was formed in the test strip and the test was interpreted as positive. In other words, the site inspected was contaminated by the indicator fungus, Stachybotris chartrum .

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

L'invention concerne un dispositif à bande d'essai doté d'une partie de prétraitement recouverte par un couvercle (2) présentant une ouverture (3) et fixé avec des charnières (A). La partie de prétraitement, servant de bande d'essai (non illustrée), est montée sur le même support (1). Le couvercle (2) et la partie de couvercle du support, pourvus de moyens (7, 8 et 9) supportant, immobilisant et fixant la position des couches de prétraitement, forment un compartiment (6) destiné à recueillir l'excès d'échantillons et régulent l'écoulement d'une solution de dosage et d'un diluant. Le dispositif d'essai est utile dans les procédés d'essai sur le terrain et les tests cliniques, notamment dans les situations d'urgence lorsqu'un résultat rapide est requis.
PCT/FI2000/000914 1999-10-21 2000-10-20 Dispositif a bande d'essai dote d'une partie de pretraitement a couvercle WO2001029558A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2001532099A JP2003512624A (ja) 1999-10-21 2000-10-20 蓋を備えた前処理部を持つ試験ストリップを備えた装置
AU79286/00A AU7928600A (en) 1999-10-21 2000-10-20 A test strip provided device with a lid-provided pretreatment portion
EP00969615A EP1222458A1 (fr) 1999-10-21 2000-10-20 Dispositif a bande d'essai dote d'une partie de pretraitement a couvercle

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI19992286 1999-10-21
FI992286 1999-10-21

Publications (1)

Publication Number Publication Date
WO2001029558A1 true WO2001029558A1 (fr) 2001-04-26

Family

ID=8555487

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2000/000914 WO2001029558A1 (fr) 1999-10-21 2000-10-20 Dispositif a bande d'essai dote d'une partie de pretraitement a couvercle

Country Status (5)

Country Link
EP (1) EP1222458A1 (fr)
JP (1) JP2003512624A (fr)
CN (1) CN1145796C (fr)
AU (1) AU7928600A (fr)
WO (1) WO2001029558A1 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016352A1 (fr) * 2001-08-10 2003-02-27 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Anticorps monoclonaux anti-champignons, et procedes d'utilisation
EP1538444A1 (fr) * 2003-12-05 2005-06-08 HUMAN Gesellschaft für Biochemica und Diagnostica mbH Dispositif de test
GB2435927A (en) * 2006-03-03 2007-09-12 Ethicon Inc Sample collection and testing device with pivot arm
EP1908522A1 (fr) * 2006-10-03 2008-04-09 Meridian Bioscience, Inc. Dispositif de test immunologique et procédé d'utilisation
US8119393B2 (en) 2005-06-28 2012-02-21 Zbx Corporation Membrane array and analytical device
JP2012168051A (ja) * 2011-02-15 2012-09-06 Beseru:Kk イムノクロマトグラフィー法に用いる検査容器
EP2560005A1 (fr) * 2010-04-14 2013-02-20 Nitto Boseki Co., Ltd Instrument d'analyse pour la mesure d'un analyte dans un échantillon et procédé pour la mesure d'un analyte l'utilisant
US8877142B2 (en) 2006-06-20 2014-11-04 Johnson & Johnson Ab Assay device and method
US9168526B2 (en) 2009-06-19 2015-10-27 Zbx Corporation Hinged cap for diagnostic device
EP3028765A1 (fr) * 2005-01-31 2016-06-08 Realbio Technologies Ltd. Dispositif capillaire a flux lateral de reaction par etapes multiples
US9726581B2 (en) 2011-12-22 2017-08-08 Realbio Technologies Ltd. Sequential lateral flow capillary device for analyte determination
CN107727648A (zh) * 2017-10-25 2018-02-23 上海菲伽生物科技有限公司 试纸颜色反应加速装置
US9952211B2 (en) 2008-06-29 2018-04-24 Realbio Technologies Ltd. Liquid-transfer device particularly useful as a capturing device in a biological assay process
US10048262B2 (en) 2012-06-13 2018-08-14 Asahi Kasei Kabushiki Kaisha Method for detecting specific substance in milk
US10073091B2 (en) 2014-08-08 2018-09-11 Ortho-Clinical Diagnostics, Inc. Lateral flow assay device
WO2020127837A3 (fr) * 2018-12-19 2020-09-24 Gentian As Procédés de détermination du taux d'hématocrite dans un échantillon de sang total
CN112903744A (zh) * 2019-12-04 2021-06-04 爱尔伯股份公司 测试条支架

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100883555B1 (ko) * 2005-11-15 2009-02-17 한메딕스 주식회사 체액의 정량 및 정성 분석장치
CN101017169B (zh) * 2006-07-26 2012-07-18 艾博生物医药(杭州)有限公司 生物样本分析装置
JP5249534B2 (ja) * 2007-07-09 2013-07-31 大塚製薬株式会社 試験紙測定容器
KR101894100B1 (ko) * 2012-02-29 2018-08-31 고려대학교 산학협력단 바이오 센서
CN104142392B (zh) * 2014-08-18 2015-12-09 深圳市领治医学科技有限公司 一种微量样本检测试纸
US9377457B1 (en) * 2015-10-19 2016-06-28 Naishu Wang Progressive compression driven flow cartridge for analyte detecting strip and method
JP6692061B2 (ja) * 2016-02-05 2020-05-13 公益財団法人科学技術交流財団 保持具及び検査キット
CN106645681B (zh) * 2016-10-31 2018-12-18 广州科方生物技术股份有限公司 一种用于免疫层析测定的阻断剂试剂盒及其使用方法
US10634591B2 (en) * 2017-03-13 2020-04-28 Tokitae Llc Device for concentration of biological sample prior to immunoassay
JP6985921B2 (ja) * 2017-12-20 2021-12-22 積水メディカル株式会社 イムノクロマト検査用デバイス
CN110018301B (zh) * 2018-01-09 2024-06-25 上海八通生物科技股份有限公司 一种组合式免疫层析装置
CN108982832A (zh) * 2018-09-28 2018-12-11 蓝怡科技集团股份有限公司 一种免疫诊断用检测装置
WO2021015273A1 (fr) * 2019-07-23 2021-01-28 田中貴金属工業株式会社 Outil d'inspection d'échantillon liquide
CN111474352B (zh) * 2020-04-29 2023-12-22 北京乐普诊断科技股份有限公司 一种新型冠状病毒covid-2019检测卡及制备方法
CN113281504B (zh) * 2020-11-11 2022-03-08 杭州微策生物技术股份有限公司 一种新型免疫层析检测装置
WO2022253108A1 (fr) * 2021-06-02 2022-12-08 厦门为正生物科技股份有限公司 Appareil de test pliant et son procédé d'utilisation

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985005686A1 (fr) * 1982-12-29 1985-12-19 Polaroid Corporation Element multicouche pour analyse
EP0306336A2 (fr) * 1987-09-04 1989-03-08 Syntex (U.S.A.) Inc. Dispositif d'essai à multiples orifices
EP0323605A2 (fr) * 1987-12-21 1989-07-12 Abbott Laboratories Appareil et méthodes de test chromatographique de liaison
EP0582231A1 (fr) * 1992-08-03 1994-02-09 Becton, Dickinson and Company Essai à phase solide
WO1994015215A1 (fr) * 1992-12-29 1994-07-07 Oy Medix Biochemica Ab Bandelettes d'essai pour immunodosages
EP0806666A2 (fr) * 1996-05-09 1997-11-12 Syntron Bioresearch, Inc. Procédé et appareil pour essais de sang complet en un seul temps
US5820826A (en) * 1992-09-03 1998-10-13 Boehringer Mannheim Company Casing means for analytical test apparatus
US5985675A (en) * 1997-12-31 1999-11-16 Charm Sciences, Inc. Test device for detection of an analyte

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985005686A1 (fr) * 1982-12-29 1985-12-19 Polaroid Corporation Element multicouche pour analyse
EP0306336A2 (fr) * 1987-09-04 1989-03-08 Syntex (U.S.A.) Inc. Dispositif d'essai à multiples orifices
EP0323605A2 (fr) * 1987-12-21 1989-07-12 Abbott Laboratories Appareil et méthodes de test chromatographique de liaison
EP0582231A1 (fr) * 1992-08-03 1994-02-09 Becton, Dickinson and Company Essai à phase solide
US5820826A (en) * 1992-09-03 1998-10-13 Boehringer Mannheim Company Casing means for analytical test apparatus
WO1994015215A1 (fr) * 1992-12-29 1994-07-07 Oy Medix Biochemica Ab Bandelettes d'essai pour immunodosages
EP0806666A2 (fr) * 1996-05-09 1997-11-12 Syntron Bioresearch, Inc. Procédé et appareil pour essais de sang complet en un seul temps
US5985675A (en) * 1997-12-31 1999-11-16 Charm Sciences, Inc. Test device for detection of an analyte

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016352A1 (fr) * 2001-08-10 2003-02-27 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Anticorps monoclonaux anti-champignons, et procedes d'utilisation
US7368256B2 (en) 2001-08-10 2008-05-06 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Antibodies against Stachybotrys chartarum and methods for their use
EP1538444A1 (fr) * 2003-12-05 2005-06-08 HUMAN Gesellschaft für Biochemica und Diagnostica mbH Dispositif de test
US10335783B2 (en) 2005-01-31 2019-07-02 Realbio Technologies, Ltd. Multistep reaction lateral flow capillary device
EP3028765A1 (fr) * 2005-01-31 2016-06-08 Realbio Technologies Ltd. Dispositif capillaire a flux lateral de reaction par etapes multiples
US8119393B2 (en) 2005-06-28 2012-02-21 Zbx Corporation Membrane array and analytical device
AU2007220303B2 (en) * 2006-03-03 2012-08-23 Ethicon, Inc. Sample collection and testing device with pivot arm
GB2435927A (en) * 2006-03-03 2007-09-12 Ethicon Inc Sample collection and testing device with pivot arm
US9606112B2 (en) 2006-06-20 2017-03-28 Johnson & Johnson Ab Assay device and method
US8877142B2 (en) 2006-06-20 2014-11-04 Johnson & Johnson Ab Assay device and method
AU2007205745B2 (en) * 2006-10-03 2011-03-03 Meridian Bioscience, Inc. Immunoassay test device and method of use
EP1908522A1 (fr) * 2006-10-03 2008-04-09 Meridian Bioscience, Inc. Dispositif de test immunologique et procédé d'utilisation
US11280785B2 (en) 2008-06-29 2022-03-22 Realbio Technologies Ltd. Liquid-transfer device particularly useful as a capturing device in a biological assay process
US9952211B2 (en) 2008-06-29 2018-04-24 Realbio Technologies Ltd. Liquid-transfer device particularly useful as a capturing device in a biological assay process
US9168526B2 (en) 2009-06-19 2015-10-27 Zbx Corporation Hinged cap for diagnostic device
EP2560005A4 (fr) * 2010-04-14 2014-04-09 Nitto Boseki Co Ltd Instrument d'analyse pour la mesure d'un analyte dans un échantillon et procédé pour la mesure d'un analyte l'utilisant
EP2560005A1 (fr) * 2010-04-14 2013-02-20 Nitto Boseki Co., Ltd Instrument d'analyse pour la mesure d'un analyte dans un échantillon et procédé pour la mesure d'un analyte l'utilisant
US10670586B2 (en) 2010-04-14 2020-06-02 Nitto Boseki Co., Ltd. Test instrument for measuring analyte in sample by an aggregation assay using a metal colloid and using a reagent attached in a dry state in a reaction chamber, and method for measuring analyte using same
JP2012168051A (ja) * 2011-02-15 2012-09-06 Beseru:Kk イムノクロマトグラフィー法に用いる検査容器
US9726581B2 (en) 2011-12-22 2017-08-08 Realbio Technologies Ltd. Sequential lateral flow capillary device for analyte determination
US10048262B2 (en) 2012-06-13 2018-08-14 Asahi Kasei Kabushiki Kaisha Method for detecting specific substance in milk
US10545146B2 (en) 2012-06-13 2020-01-28 Asahi Kasei Kabushiki Kaisha Method for detecting specific substance in milk
US10073091B2 (en) 2014-08-08 2018-09-11 Ortho-Clinical Diagnostics, Inc. Lateral flow assay device
CN107727648A (zh) * 2017-10-25 2018-02-23 上海菲伽生物科技有限公司 试纸颜色反应加速装置
WO2020127837A3 (fr) * 2018-12-19 2020-09-24 Gentian As Procédés de détermination du taux d'hématocrite dans un échantillon de sang total
CN112903744A (zh) * 2019-12-04 2021-06-04 爱尔伯股份公司 测试条支架

Also Published As

Publication number Publication date
CN1382257A (zh) 2002-11-27
CN1145796C (zh) 2004-04-14
EP1222458A1 (fr) 2002-07-17
JP2003512624A (ja) 2003-04-02
AU7928600A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
EP1222458A1 (fr) Dispositif a bande d'essai dote d'une partie de pretraitement a couvercle
AU2002330899B2 (en) Test strip for a lateral flow assay
RU2358267C2 (ru) Устройство и способ для одновременного определения группы крови, серологического перекрестного контроля и анализа на антитела
AU2009233694B2 (en) Analyte collection and detection devices
EP0296724B1 (fr) Essai et dispositif utilisant une membrane non-buvant permettant un courant latéral
US9606112B2 (en) Assay device and method
EP0806666B1 (fr) Procédé et appareil pour essais de sang complet en un seul temps
DK1824991T3 (en) Device and method for the detection of analytes
US7288413B2 (en) Combined chemical and immunochemical fecal occult blood test
CA2493616A1 (fr) Dispositif de diagnostic rapide, dosage et tampon multifonctionnel
US5759866A (en) Device and method for assaying biological components in sample
AU2002330899A1 (en) Test strip for a lateral flow assay
US5753497A (en) Diagnostic assay providing blood separation
JPH0627738B2 (ja) 特異的結合アッセイ装置および方法
KR20060109595A (ko) 개선된 측면 이동 면역분석법과 이를 위한 디바이스

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000969615

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 532099

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 008146152

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 10089541

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000969615

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000969615

Country of ref document: EP